Applied Molecular Transport Inc. Common Stock
AMTI
AMTI was delisted on the 26th of December, 2023.
49 hedge funds and large institutions have $23M invested in Applied Molecular Transport Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 15 closing their positions.
3,700% more call options, than puts
Call options by funds: $304K | Put options by funds: $8K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less funds holding
Funds holding: 56 → 49 (-7)
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
70% less capital invested
Capital invested by funds: $76.6M → $23M (-$53.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.28M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$698K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$285K |
| 4 |
Renaissance Technologies
New York
|
+$260K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$4.11M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$3M |
| 3 |
Morgan Stanley
New York
|
-$1.14M |
| 4 |
FFVM
Founders Fund VI Management
San Francisco,
California
|
-$883K |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$372K |
AMTI Hedge Fund Activity: Q3 2022 in Review
49 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Applied Molecular Transport Inc. Common Stock (AMTI) for Q3 2022, worth a combined $23M — down 70% from $76.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AMTI and 8 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 11 added.
The largest buyer was UBS Group, opening a new position worth an estimated $2.28M. The largest seller was Capital World Investors, cutting an estimated $4.11M.
- 49 institutional investors held Applied Molecular Transport Inc. Common Stock (AMTI) as of Q3 2022, down from 56 in Q2 2022.
- Funds reported $23M of Applied Molecular Transport Inc. Common Stock stock for Q3 2022, down 70% quarter-over-quarter.
- 8 funds opened new Applied Molecular Transport Inc. Common Stock positions in Q3 2022 and 15 closed out, a net change of -7 holders.
- The largest Applied Molecular Transport Inc. Common Stock buyer in Q3 2022 was UBS Group, an estimated $2.28M added.
- The largest Applied Molecular Transport Inc. Common Stock seller in Q3 2022 was Capital World Investors, an estimated $4.11M sold.
Based on aggregated 13F filings for Q3 2022.